Insulin initiation and titration for people with type 2 diabetes managed in primary care and guided by continuous glucose monitoring
The Lancet Primary Care · 2026-08 · 2 (8) · 100193
DOI: 10.1016/j.lanprc.2026.100193 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Primary Care, 2026-08. Verfasst von Ramzi A Ajjan und 8 weiteren Autor:innen. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Diabetes Care Inc, The Slovenian Research and Innovation Agency.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The global burden of diabetes is projected to reach 1·31 billion people by 2050, the majority of whom will have type 2 diabetes (T2D). There are considerable regional and socioeconomic inequities in access to care for people with T2D, and providing care for such a large number of individuals will require changes to current management approaches. Chronic hyperglycaemia directly contributes to premature morbidity and mortality while impairing quality of life. Therefore, timely intervention to improve hyperglycaemia will reduce long-term complications and spiralling diabetes health-care costs. However, treatment inertia is common, particularly with insulin initiation and titration, related to the complexities involved and concerns over hypoglycaemia. This inertia is particularly true for people with T2D managed in primary health care. The increasing use of continuous glucose monitoring (CGM) systems has enabled more effective management of individuals with diabetes, including timely initiation and titration of insulin therapy for people with T2D, typically started as basal insulin. As CGM metrics can safely and effectively guide health-care professionals and individuals with diabetes to refine insulin treatment, practical guidance on how to best apply this information in clinical practice is needed. In this Viewpoint, we propose practical algorithms for using well established CGM metrics in the management of basal-insulin initiation, titration, and intensification, as well as in the process of insulin deintensification. The collective aim of this expert guidance is to optimise glycaemia by not only lowering high glucose levels, but also minimising hypoglycaemia to improve outcomes and quality of life for individuals with T2D.
Förderung
- Abbott Diabetes Care Inc
- The Slovenian Research and Innovation Agency
Zitieren
APA
Ajjan, R. A., Battelino, T., Cos, X., Prato, S. D., Mathieu, C., Almehthel, M., Seufert, J., Guerci, B., & Seidu, S. (2026). Insulin initiation and titration for people with type 2 diabetes managed in primary care and guided by continuous glucose monitoring. The Lancet Primary Care, 2(8), 100193. https://doi.org/10.1016/j.lanprc.2026.100193
Vancouver
Ajjan RA, Battelino T, Cos X, Prato SD, Mathieu C, Almehthel M, et al. Insulin initiation and titration for people with type 2 diabetes managed in primary care and guided by continuous glucose monitoring. The Lancet Primary Care. 2026;2(8):100193. doi:10.1016/j.lanprc.2026.100193
BibTeX
@article{Ajjan2026,
author = {Ajjan, Ramzi A and Battelino, Tadej and Cos, Xavier and Prato, Stefano Del and Mathieu, Chantal and Almehthel, Mohammed and Seufert, Jochen and Guerci, Bruno and Seidu, Samuel},
title = {Insulin initiation and titration for people with type 2 diabetes managed in primary care and guided by continuous glucose monitoring},
journal = {The Lancet Primary Care},
year = {2026},
volume = {2},
number = {8},
pages = {100193},
doi = {10.1016/j.lanprc.2026.100193}
}
EUVIMED